{"id":"W4327932052","doi":"10.1055/s-0042-1760567","title":"Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec (CSL222) vs. extended half-life Factor IX therapies for severe or moderately severe hemophilia B","year":2023,"lang":"en","type":"article","venue":"Hämostaseologie","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Factor IX; Haemophilia; Haemophilia B; Genetic enhancement; Clinical trial; Internal medicine; Surgery; Haemophilia A; Gene; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215091,0.0008340104,0.001279738,0.0003538678,0.0001409583,0.0006745823,0.0004714439,0.0007514528,0.01022504],"category_scores_gemma":[0.002182964,0.0001579784,0.001339412,0.0002992193,0.0006300429,0.0005750103,0.0003654223,0.001542383,0.0007750338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004457195,"about_ca_system_score_gemma":0.0005031286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004210748,"about_ca_topic_score_gemma":0.0006262611,"domain_scores_codex":[0.9977495,0.001546622,0.0001403514,0.000193269,0.0002326674,0.0001375549],"domain_scores_gemma":[0.9976548,0.001217372,0.0005184847,0.0001940174,0.0001243832,0.0002908555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8854055,0.008232742,0.001512695,0.001319799,0.001978531,0.0000317611,0.0000855546,0.0008494802,0.01396988,0.001236982,0.001065548,0.08431155],"study_design_scores_gemma":[0.1420544,0.8153179,0.01239387,0.0002639275,0.003697748,0.0001269222,0.0001002011,0.001111683,0.01501028,0.0009681095,0.008909741,0.00004514449],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752373,0.01005623,0.001512986,0.0003497475,0.0006067023,0.001666814,0.001791798,0.00005579503,0.008722641],"genre_scores_gemma":[0.9873576,0.002428504,0.00182543,0.0002502625,0.0003558111,0.001355789,0.001022444,0.00001857463,0.005385535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01022504,"threshold_uncertainty_score":0.03420615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1893468952219408,"score_gpt":0.3743744757300747,"score_spread":0.1850275805081339,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}